| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d1722281c6f74e3ee2514dac3048c56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec3d7a9a543c4214ef75cdabb2d0e04b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9581a07669e89d6c2525bc515b4b7887 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-11 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0637
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 |
| filingDate |
2010-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_803ae70dd0bc564d7a21045b8c21c4a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c936823d2e2dd5f93246d6ad66d6ee0d |
| publicationDate |
2010-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010101870-A1 |
| titleOfInvention |
Compositions and methods for generating interleukin-35-induced regulatory t cells |
| abstract |
Compositions and methods are provided for generating T cells having a regulatory phenotype from conventional T (T conv ) cells. Such compositions and methods include culturing isolated, naϊve T conv cells with an effective amount of interleukin-35 (IL-35) until the cells have the regulatory phenotype. Also provided are methods to treat subject having or susceptible to having various disorders including, for example, immune system disorders with the T cells having the regulatory phenotype. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022159575-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016180948-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9518113-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10392431-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016057651-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022216942-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017066561-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017165412-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10591465-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020033791-A1 |
| priorityDate |
2009-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |